Laporan PCu

11102011
1 nl Made Srl MurLlnl/ / 46 Lahun/ 1308687/ harl 2
Ca Cvarlum advenLage sLage + syok hlpovolumlk + uM Llpe 2
2 uewa Cede wlraLama/ L/ 24 Lahun/ harl 2
posL Lrepanasl evacuasl cloL ec SuP fronLoLemporoparleLal S + LuP
Lemporobasal S + edema cerebrl
3 1uklyo/ L/ 33 Lh/ 1313207/ harl 3
posL debrldemenL + exLernal flxasl ec Cl Llbla S 1/3 dlsLal + Cl flbula S
1/3 proxlmal (hr 12) + LeLanus generallsaLa
4 nl kadek MurLlnl/ / 24 Lahun/ 1313264/ harl 3
Ck8 + fr Maxllofaclal le lorL lll + dlsLress napas + braln swelllng + Cl
humerus S 1/3 Lengah
3 CusLl Ayu WldlaLl/ / 30 Lahun/ 01313300/ harl 2
osL v shunL ec hldrocephalus non communlcanL + sol serebrl
6 lda edanda Cde uLu uLra/ L/ 73 Lahun/ 1462313/ harl 9
SP lC8 S
1 nl Made Srl MurLlnl/ / 46 Lahun/ 1308687/ harl 2
Ca Cvarlum advenLage sLage + syok hlpovolumlk + uM Llpe 2
W M8S 7102011 PCu 9102011 darl san[lwanl
W aslen dlkonsulkan oleh 1S obgyn dengan syok dlsLrlbuLlf dd hlpovolumla posL
kemoLerapl paxus karboplamec ca ovarlum advenLage sLage
W aslen mendapaLkan kemoLerapl paxus karboplamserl 2 (8102011) Lemas (9
102011 pk 0200) mual (+) munLah (+) uemam () Lldak sadar selama 3 menlL
kemoLerapl dlsLop
W ulberlkan C2 SM ln[eksl dexameLason 10 mg clmeLldln 3 x 1 amp kalLrofen supp
soclaf 2 x 1
W (9102011 pk 0730) paslen dlkonsulkan ke lnLerna oleh karena mengalaml syok
1u 30/palpasl n 120 x/mnL dlLerapl 8L 300 cc + PALS 6 300 cc 60/palpasl
W Lab (k 833 9/10/2011) W8C 824/ Pb 1478/ PcL 42/ lL 2067/ 81 1/ C1 9/ 1
163 (108) / A11 331 (33)/ ln8 14/ SCC1 608/ SC1 788/ 8un 21/ SC 139/ 8S
342/ na 132/ k 402/
W ACu pP 743/ pCC2 19/ pC2 124/ PCC3 132/ 8L 83/ na 126/ k 38
W Selama perslapan LransporL ke PCu 1u 90/40 mmPg n
W roduksl urlne mlnlmal furosemld 20 mg
8ed 1 Parl 0
88 30 kg/ 1emp 36 C
SS cm
8es 88 30 x/mnL rh / wh / SpC2 99
C2 SM 10 LM
kv 118/76 mmPg n 147 x/mnL Cv 8 cm
P2C
Cl dlsLensl (+) shlfLlng dullness +
uC uk + produksl pekaL 100 cc/3 [am
700 cc/ 7 [am
W8C 108/ Pb 89/ PcL 264/ lL 126/ 8un
1702/ SC 139/ 8S 143/ na 131/ k 41
ACu (pk 1700 1 367 C) pP 742/ pCC2 23/
pC2 113/ 8L 67/ PCC3 162/ SaL 100
ACu (pk 2100 1 36 C) pP 736/ pCC2 28/
pC2 79/ 8L 83/ PCC3 138/ SaL 90
lnLubasl C 20/ rr 14/ fl C2 100 peep 7
SaL 97
ro Lenslon pneumoLhoraks u + efusl
pleura bllaLeral mlnlmal pasang WSu u
W ullL u3 300 cc/24 [am
W 8L 1300 cc/24 [am
W MeLoclopramld 3 x 10 mg
W ClmeLldln 3 x 1 amp
W MeLronldazole 3 x 300 mg
W araceLamol 3 x 300 mg
W PepaLln 2 x 1 Lb
W lenLanyl 23 mcg k/p
W lurosemld 10 mg/[am
W uobuLamln 10
mcg/kg88/menlL
W vascon 03 mcg/kg88/menlL
8ed 1 Parl 1
88 30 kg/ 1emp 38 C
SS cm
8es C 20 88 14 llC2 100 peep 10 rh / wh /
SpC2 99
ro Lenslon pneumoLhoraks u + efusl pleura
bllaLeral mlnlmal pasang WSu u
kv 118/76 mmPg n 147 x/mnL Cv 8 cm P2C
Cl dlsLensl (+) shlfLlng dullness +
uC uk + produksl pekaL 100 cc/3 [am
930 cc/ 21 [am
W8C 198/ Pb 119/ PcL 23/ lL 177/ na 131/ k 43
ACu (pk 0700 1 367 C) pP 734/ pCC2 44/ pC2
133/ 8L 22/ PCC3 237/ SaL 100 C 20 88
14 llC2 70 peep 10
ACu (pk 2100 1 38 C) pP 74/ pCC2 33/ pC2 149/
8L 26/ PCC3 217/ SaL 99
C 20 88 14 llC2 60 peep 10
ro Lenslon pneumoLhoraks u + efusl pleura
bllaLeral mlnlmal pasang WSu u
W ullL dlabeLasol 730 cc/24 [am
W 8L 1300 cc/24 [am
W MeLoclopramld 3 x 10 mg
W ClmeLldln 3 x 1 amp
W Soflram 2 x 1 g
W MeLronldazole 3 x 300 mg
W araceLamol 3 x 300 mg
W PepaLln 2 x 1 Lb
W lenLanyl 23 mcg k/p
W lnsulln sesual gula darah
W lurosemld 10 mg/[am
W Morphlne 20 mg/24 [am
W uobuLamln 10 mcg/kg88/menlL
W vascon 1 mcg/kg88/menlL
2 uewa Cede wlraLama/ L/ 24 Lahun/ harl 1
posL Lrepanasl evacuasl cloL ec SuP fronLoLemporoparleLal S +
LuP Lemporobasal S + edema cerebrl
W M8S 8102011 2012 PCu darl Ck l8u 9102011 pk 330
W aslen ru[ukan 8Suu glanyar dengan Ck8 + cephal hemaLom
W uaLang Lldak sadar
W 8lwayaL operasl 2008 Lrepanasl rawaL PCu dengan CAC11
W MCl paslen Ler[aLuh sendlrl saaL mengendaral sepeda moLor seLelah
mlnum mluman keras kepala membenLur LroLoar
W Lab W8C 273/ Pb 144/ PC1 426/ lL 300
W ermasalah preoperasl
W CCS L1v1M3 pupll klrl sde pupll kanan reflex (+)
W C1 scan focal fronLoparleLal S uk 10868 mm x 91 mm 10 sllce mldllne
shlfL 198 ke kanan
W 8es dllnLubasl dl Lrlage bedah
W uuranLe operasl CAC11
W uurasl 2 [am 23 menlL
W erdarahan 300 cc calran masuk krlsLalold 700 cc/kolold 300 cc/ manlLol
200 cc/ urlne 1300 cc/3 [am
8ed 2 Parl 0
88 33 kg/ 1emp 36 C
SS uC 8 +/ (3 mm/sde)
8es CvC 1v 300 cc 88 12 ll C2 30
LL 3 rh / wh / SpC2 100
kv 132/83 mmPg n 83 x/mnL
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 1700 cc/18
[am
W8C 133/ Pb 123/ PcL 371/ lL 233
SCC1 9603/ SC1 8173/ Alb 34/ 8un
83/ SC 066/ 8S 123/ na 141/ k 37
ACu (pk 0700 1 36 C) pP 739/ pCC2 31/
pC2 273/ 8L 32/ PCC3 188/ SaL 100
CvC 1v 300 cc 88 12 ll C2 40
LL 3
ACu (pk 1400 1 36 C) pP 738/ pCC2 32/
pC2 209/ 8L 33/ PCC3 189/ SaL 100

W ullL u3 300 cc/24 [am

W 8L 300 cc/24 [am
W naCl 1000 cc/24 [am
W Ceflrom 2 x 1 g
W ClLlcholln 3 x 300 mg
W 8anlLldln 3 x 30 mg
W araceLamol 3 x 1 g
W lenLanyl 300 mcg/24 [am
8ed 2 Parl 1
88 33 kg/ 1emp 36 C
SS uC 8 / (3 mm/sde)
refleks cornea
8es asssLed 1v 300 cc 88 12 ll
C2 40 LL 3 rh / wh /
SpC2 100 gag refleks
kv 106/43 mmPg n 79 x/mnL
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 1730
cc/21 [am
ACu (pk 0700 1 36 C) pP 743/
pCC2 33/ pC2 184/ 8L 1/ PCC3
219/ SaL 100 na 141/ k 37
W ullL pepLlsol 6 x 200 cc
W 8L 300 cc/24 [am
W naCl 1000 cc/24 [am
W Ceflrom 2 x 1 g
W ClLlcholln 3 x 300 mg
W 8anlLldln 3 x 30 mg
W araceLamol 3 x 1 g
W vascon 003
mcg/kgbb/mnL
3 1uklyo/ L/ 33 Lh/ 1313207/ harl 2
posL debrldemenL + exLernal flxasl ec Cl Llbla S 1/3 dlsLal +
Cl flbula S 1/3 proxlmal (hr 12) + LeLanus generallsaLa
W aslen M8S 7/10/2011 pk 1640masuk PCu darl Ck l8u 8102011 pk 0900
W aslen ru[ukan darl 8S udayana dengan susp LeLanus ec fr crurls S
W nyerl pada kakl klrl se[ak 12 harl yang SM8S seLelah [aLuh darl aLap rumah 1
harl SM8S paslen mulal sukar membuka muluL
W 8lwayaL penyaklL slsLemlk ()
W ermasalahan pre operasl
W 1eLanus generallsaLa (Lrlsmus (+))
W PlperLensl sLadlum 2
Lab
W W8C 12/ Pb 143/ PcL 373/ lL 294/ SCC1 1224/ SC1 176/ Alb 398/ 8un
1804/ SC 09/ 8S 1146/ na 1331/ k 47
W LkC nS8 83 x/mnL
W 8o Lhoraks C18 48 po lnfllLraL ()
uuranLe operasl
W uurasl 23 [am
W erdarahan 300 cc calran masuk krlsLalold 1800 cc produksl urlne 130 cc/23
[am
W Pemodlnamlk duranLe operasl 1u 110140/ 6090 mmPg n 6090 x/mnL
8ed 3 Parl 0
88 33 kg/ 1emp 363 C
SS apaLls
8es SM 10 LM Lrlsmus (+) 88 18
x/mnL rh / wh / SpC2 100
kv 132/83 mmPg n 83 x/mnL
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh
130cc/23 [am
W8C 148/ Pb 113/ PcL 223/ lL
273
SCC1 243/ SC1 132/ 8un 217/
SC 08/ 8S 132/ na 133/ k 43
W ullL u3 300 cc/24 [am
W 8L 1300 cc/24 [am
W CefLrlaxon 2 x 1 g
W CenLamlcln 2 x 80 mg
W 8anlLldln 3 x 30 mg
W Mldazolam 30 mg/24
[am
W lenLanyl 300 mcg/24
[am
8ed 3 Parl 1
88 33 kg/ 1emp 374 C
SS apaLls
8es SM 10 LM Lrlsmus 88 18
x/mnL rh / wh / SpC2 100

kv 133/72 mmPg n 92 x/mnL

Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 1630
cc/18 [am
W epLlsol 600 cc/24
[am
W 8L 1300 cc/24 [am
W CefLrlaxon 2 x 1 g
W CenLamlcln 2 x 80 mg
W 8anlLldln 3 x 30 mg
W Mldazolam30 mg/24
[am + k/p 23 mg blla
ke[ang
W lenLanyl 300 mcg/24
[am
8ed 3 Parl 2
88 33 kg/ 1emp 373 C
SS apaLls
8es SM 10 LM Lrlsmus 88 18
x/mnL rh / wh / SpC2 100

kv 133/72 mmPg n 92 x/mnL

Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 1230
cc/21 [am
W epLlsol 600 cc/24
[am
W 8L 1300 cc/24 [am
W CefLrlaxon 2 x 1 g
W CenLamlcln 2 x 80 mg
W 8anlLldln 3 x 30 mg
W Mldazolam72 mg/24
[am + k/p 23 mg blla
ke[ang
W lenLanyl 130 mcg/24
[am
4 nl kadek MurLlnl/ / 24 Lahun/ 1313264/ harl 2
Ck8 + fr Maxllofaclal le lorL lll + dlsLress napas + braln
swelllng + Cl humerus S 1/3 Lengah
M8S 7102011 pk 2233 masuk PCu 892011 pk 0600 darl
Lrlage bedah
uaLang Lldak sadar seLelah kecelakaan 1 [am SM8S
MCl dlbonceng nalk sepeda moLor kemudlan dlLabrak mobll darl
arah berlawanan
ermasalahan pra arlval
SS CCS L1v1M3 8 +/+ anlsokor kl ka
C1 scan edema cerebrl (+) focal lesl () mldllne shlfL ()
8es frakLur maxllofaclal dengan alrway compromlse lnLubasl dengan
L1 no 7 klnklng cuff + bagglng
kv P8 100 x/mnL 1u 80/30 mmPg resuslLasl calran hlngga 3 llLer
(8L 2000 cc+ PALS 6 1000 cc) 1u 100/70 mmPg
Cervlcal A/ laL dbn
1horax phoLo dbn
8ed 4 Parl 0
88 30 kg/ 1emp 36 C
SS uC 8 +/+ anlsokor kl ka rhlnore +/+
oLhore +/+
8es on venLllaLor supporL
CvC 300 88 12 llC2 100 LL 3
ves +/+ rh / wh / SpC2 100
kv 100/60 mmPg n 80 x/mnL
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh
9102011 1700
ACu (pk 0700 1 36 C) pP 734/ pCC2 42/
pC2 361/ 3/ 227/ 100 na 136/ k 29
CvC 1v 300 88 12 llC2 30 LL 3
k 0800 136 C pP 738/ 39/ 180/ 18/ 231/
100 / na 137/ k 32
W8C 127/ Pb 67/ PcL 20/ lL 200 W8C
113/ Pb 112/ PcL 32/ lL 134 (posL
Lransfusl)
SCC1 2387/ SC1 1891/ 8un 76/ SC 073/
8S 122/
W ullL u3 300 cc/24 [am
W 8L 1000 cc/24 [am
W 8C 730 cc
W kCl 30 meq / 6 [am
W CefLrlaxon 2 x 1 g
W ClLlcholln 3 x 300 mg
W henlLoln 3 x 100 mg
W keLorolac 3 x 30 mg
W lenLanyl 300 mcg/24 [am
8ed 4 Parl 1
88 30 kg/ 1emp 36 C
SS uC 8 +/+ anlsokor kl ka
8es on venLllaLor supporL
SlMv 10 480 llC2 40 LL 3
ves +/+ rh / wh / SpC2 100
kv 107/69 mmPg n 107 x/mnL
CvC 13 cmP2C
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 2023
cc/24 [am 167 cc/kg88/[am
9102011 1700
ACu (pk 2100 1 368 C) pP 733/
pCC2 36/ pC2 163/ 63/ 19/ 99
na 133/ k 32
W ullL u3 300 cc/24 [am
W 8L 1300 cc/24 [am
W kCl 30 meq/ 6 [am
W CefLrlaxon 2 x 1 g
W ClLlcholln 3 x 300 mg
W henlLoln 3 x 100 mg
W keLorolac 3 x 30 mg
W lenLanyl 300 mcg/24
[am
8ed 4 Parl 2
88 30 kg/ 1emp 36 C
SS uC 8 +/+ anlsokor kl ka
8es on venLllaLor supporL
SlMv 10 480 llC2 40 LL 3
ves +/+ rh / wh / SpC2 100
kv 107/69 mmPg n 107 x/mnL CvC
13 cmP2C
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 1230 cc/21
[am
9102011 1700
ACu (pk 2100 1 368 C) pP 739/
pCC2 37/ pC2 133/ 03/ 249/ 99
na 132/ k 34 cpap ps 10
cpap ps 6
Wbc 146/ hb 99/ hcL 28 / plL 160
W ullL u3 300 cc/24 [am
W 8L 1300 cc/24 [am
W kCl 30 meq/ 6 [am
W CefLrlaxon 2 x 1 g
W ClLlcholln 3 x 300 mg
W henlLoln 3 x 100 mg
W keLorolac 3 x 30 mg
W lenLanyl 300 mcg/24 [am
3 CusLl Ayu WldlaLl/ / 30 Lahun/ 01313300/ harl 1
osL v shunL ec hldrocephalus non communlcanL + sol serebrl
W M8S 9102011 pk 0640 PCu 9102011 1740
W aslen ru[ukan 8S 8adung dengan susp SP
W dlLemukan dengan penurunan kesadaran se[ak pk 430 9102011 Sebelumnya paslen
mengeluhkan nyerl kepala selama 3 Lahun hllang Llmbul 3 Lahun yang lalu sempaL C1 scan
dlkeLahul ada Lumor berobaL alLernaLlf
W 1 harl SM8S paslen mengeluh munLah dan nyerl kepala hebaL
W 1ldak dlLemukan kelemahan separuh Lubuh ke[ang suara pelo dan kesemuLan sebelumnya
W 8lwayaL penyaklL slsLemlk ()
ermasa|ahan preoperas|
1 SS CCS L1v1M2 8 +/+ mldrlasls 4 mm/4 mm C1 scan hldrocephalls non comunlcan + sol
cerebrl
2 8esp apneu rh / wh /
3 kv 1u 180/100 mmPg n 120 x/mnL
9102011 W8C 118/ Pb 138/ PcL 438/ lL 193
SCC1 448/ SC1 316/ 8un 11/ SC 1/ 8S 113/ na 142/ k 416/ chol 270/ PuL 41/ LuL 206/ 1C
114
8onLgen Lhoraks C18 36 pulmo dbn
Durante operas| CAC11
uurasl 33 menlL
Pemodlnamlk 1u 98200/72120 mmPg n 86120 x/mnL
Calran masuk krlsLalold 2030 cc perdarahan mlnlmal
roduksl urlne 200 cc/1 [am 40 menlL
8ed 3 Parl 0
88 70 kg/ 1emp 36 C
SS uC 8 +/+ mlnlmal (mldrlasls 4/4
mm)
8es on venLllaLor supporL
CvC 300 88 12 llC2 30 LL 3
ves +/+ rh / wh / SpC2 100
kv 90/61 mmPg n 112 x/mnL
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 200 cc/13 [am
9102011 1700
ACu pP 738/ pCC2 33/ pC2 83/ 38/
207/ 96 CvC 1v 600 88 12 llC2
30 LL 3
W8C 114/ Pb 129/ PcL 363/ lL 133
SCC1 3689/ SC1 2474/ 8un 1363/ SC
1073/ 8S 122/ na 148/ k 37
W ullL u3 300 cc/24 [am
W 8L 1300 cc/24 [am
W Laplrom 3 x 1 g
W Laplbal 3 x 300 mcg
W lenLanyl 300 mcg/24 [am
8ed 3 Parl 1
88 70 kg/ 1emp 36 C
SS somnolen 8 +/+ mlnlmal
(mldrlasls 4/4 mm)
8es on venLllaLor supporL
CvC 600 88 12 llC2 30 LL 3
ves +/+ rh / wh / SpC2 100
kv 90/61 mmPg n 112 x/mnL
Cl dlsLensl () 8u (+) n
uC uk + produksl [ernlh 200 cc/13
[am
9102011 1700
ACu (L 386/ 1300)pP 738/ pCC2 41/
pC2 138/ 08/ 243/ 100
asslsLed 1v 600 88 12 llC2 30
LL 10
na 133/ k 39
W ullL u3 300 cc/24 [am
W 8L 1300 cc/24 [am
W Laplrom 3 x 1 g
W Laplbal 3 x 300 mcg
W 8anlLldln 3 x 30 mg
6 lda edanda Cde uLu uLra/ L/ 73 Lahun/ 1462313/ harl 6
SP lC8 S
W M8S 2 102011
W aslen Lldak sadar se[ak pk 0830 (2/10/2011)
W 8lwayaL ke[ang 1 x
W 8lwayaL P1 (+) rlwayaL sLroke 10 bulan yang lalu
Lrepanasl dengan sekuele (+) lemah slsl Lubuh
slsl klrl
W W8C 12/ Pb 163/ PC1 484/ lL 276
W ACu pP 738/ pCC2 32/ pC2 127/ 8L 33/ PCC3
189/ SpC2 99 / na 139/ k 29
W SCC1 23/ SC1 16/ 8un 9/ SC 086/ CuS 96
Parl 0
W SS L1v1M3 8 +/+
anlsokor ka kl
W 8esp SponLan SM 10
lpm rr 2024 x/mnL rh /
wh / SpC2 100
W kv n 124 x/mnL 1u
148/102 mmPg
W Cl dlsLensl () 8u (+) n
W uC uk (+)
W MS hemlparesls spasLlk
S flaksld u
W 8L 2000 cc/24 [am
W ManlLol 6 x 100 cc
W ClLlcholln 3 x 230 mg
W 8anlLldln 3 x 30 mg
W Asam LranexamaL 3 x 1 g
Parl 1
W SS L1v1M3 8 +/+
anlsokor ka kl
W 8esp SponLan SM 10
lpm rr 2024 x/mnL rh /
wh / SpC2 100
W kv n 124 x/mnL 1u
148/102 mmPg
W Cl dlsLensl () 8u (+) n
W uC 2900/ 19 [am
W MS hemlparesls spasLlk
S flaksld u
W 1 383 C
W epLlsol 600 cc/24 [am
W 8L 1000 cc/24 [am
W Amlnofusln 300 cc/24 [am
W ManlLol 3 x 100 cc
W ClLlcholln 3 x 230 mg
W 8anlLldln 3 x 30 mg
W Asam LranexamaL 3 x 1 g
W MeLamlzole 1 g k/p
W CapLoprll 2 x 30 mg
W nefedlpln 3 x 10 mg
Parl 2
W SS L1v1M3 8 +/+
anlsokor ka kl
W 8esp SponLan SM 10
lpm rr 2024 x/mnL rh /
wh / SpC2 100
W kv n 124 x/mnL 1u
148/102 mmPg
W Cl dlsLensl () 8u (+) n
W uC 1430/ 24 [am
W MS hemlparesls spasLlk
S flaksld u
W 1 39 C
W epLlsol 730 cc/24 [am
W 8L 1000 cc/24 [am
W Amlnofusln 300 cc/24 [am
W ManlLol 3 x 100 cc
W ClLlcholln 3 x 230 mg
W 8anlLldln 3 x 30 mg
W Asam LranexamaL 3 x 1 g
W MeLamlzole 1 g k/p
W CapLoprll 2 x 30 mg
W nefedlpln 3 x 10 mg
W araceLamol 4 x 300 mg
Parl 3
W SS L2v2M3 8 +/+
lsokor
W 8esp SponLan SM 10 lpm
rr 2024 x/mnL rh / wh /
SpC2 100
W kv n 124 x/mnL 1u
148/102 mmPg
W Cl dlsLensl () 8u (+) n
W uC 1700/ 24 [am
W MS hemlparesls spasLlk S
flaksld u
W 1 39 C
W epLlsol 730 cc/24 [am
W 8L 1000 cc/24 [am
W Amlnofusln 300 cc/24 [am
W ManlLol 3 x 100 cc
W ClLlcholln 3 x 230 mg
W 8anlLldln 3 x 30 mg
W Asam LranexamaL 3 x 1 g
W MeLamlzole 1 g k/p
W CapLoprll 2 x 30 mg
W nefedlpln 3 x 10 mg
W araceLamol 4 x 300 mg
W Amlodaron 2 x 1 Lb
Parl 4
W SS L2v2M3 8 +/+ lsokor
W 8esp SponLan SM 10 lpm rr
2024 x/mnL rh / wh /
SpC2 100
W kv n 124 x/mnL 1u 148/102
mmPg
W Cl dlsLensl () 8u (+) n
W uC 1600/ 24 [am
W MS hemlparesls spasLlk S
flaksld u
W 1 39 C
W epLlsol 730 cc/24 [am
W 8L 1000 cc/24 [am
W Amlnofusln 300 cc/24 [am
W ManlLol 3 x 100 cc
W ClLlcholln 3 x 230 mg
W 8anlLldln 3 x 30 mg
W Asam LranexamaL 3 x 1 g
W CeLrlaxon 3 x 1 g
W MeLamlzole 1 g k/p
W CapLoprll 2 x 30 mg
W nefedlpln 3 x 10 mg
W araceLamol 4 x 300 mg
W Amlodaron 2 x 1 Lb
Parl 3
W SS L2v2M3 8 +/+ lsokor
W 8esp SponLan SM 10 lpm rr
2024 x/mnL rh / wh /
SpC2 100
W kv n 124 x/mnL 1u 148/102
mmPg
W Cl dlsLensl () 8u (+) n
W uC 1300/ 24 [am
W MS hemlparesls spasLlk S
flaksld u
W 1 39 C
W epLlsol 730 cc/24 [am
W 8L 1000 cc/24 [am
W Amlnofusln 300 cc/24 [am
W ManlLol 3 x 100 cc
W ClLlcholln 3 x 230 mg
W 8anlLldln 3 x 30 mg
W Asam LranexamaL 3 x 1 g
W CeLrlaxon 3 x 1 g
W MeLamlzole 1 g k/p
W CapLoprll 2 x 30 mg
W nefedlpln 3 x 10 mg
W araceLamol 4 x 300 mg
W Amlodaron 2 x 1 Lb
1erlma kaslh